DATAPHARM A/S: Financial statements 2023
CVR: 72323211
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
DATAPHARM A/S (CVR 72323211) has filed annual accounts for 2023. In 2023, the company reported a net result of DKK 703,717 compared with DKK 840,867 the year before. Equity in the 2023 report amounted to DKK 10,442,254. The solvency ratio was 76.9%.
- Profit/Loss
- DKK 703,717
- Equity
- DKK 10,442,254
- Total Assets
- DKK 13,570,195
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | - | 704 t. | 10.4 mio. | 0 |
| 2022 | - | - | 841 t. | 9.7 mio. | 0 |
| 2021 | - | - | 602 t. | 8.9 mio. | 0 |
| 2020 | - | - | 305 t. | 8.3 mio. | 0 |
| 2019 | - | - | -2.6 mio. | 8 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
DATAPHARM A/S has published its annual report for 2022. The net result was DKK 840,867.
As of April 20, 2023, Helle Steen Sørensen has left the board of directors of DATAPHARM A/S.
About DATAPHARM A/S
DATAPHARM A/S is a Danish company of the type Aktieselskab based in København K, founded in 1983. The company is registered under the industry Computerprogrammering. The management consists of Henrik Bruun. The board consists of Dan Asmussen (chair), Dorte Kamp Teglgård, Jonas Arendal Grønskov and Mia Bendix Andersen. The company is owned by D.A. INVEST OG UDVIKLING A/S. The company has 4 employees (2004). In 2025, the company reported a net result of DKK 657,407 compared with DKK 650,613 the year before. Equity in the 2025 report amounted to DKK 11,750,274.